Multivariate analysis revealed that subjects with low-grade inflammation (hs-CRP level ≥3 mg/l) showed a slightly increased risk of developing postmenopausal breast cancer (HR, 1.28; 95% CI, 0.97-1.67), but this did not reach statistical significance.
← all excerpts
Association between body mass index combined with high-sensitivity C-reactive protein and the risk of postmenopausal breast cancer: A prospective cohort study.
1
—
—